Teri Willey
InvestorP2C Managing Director & Officer at Pathway to Cures
About
Willey joined NBDF in November 2022 to launch and lead Pathway to Cures. She has over 35 years of experience commercializing early-stage research, previously serving as founding managing director of IU Ventures' Indiana Philanthropic Venture Fund, founding chief executive of Cambridge Enterprise Ltd, and co-founder of ARCH Development Partners.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Brian Andrew
Investment Committee Chair at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Gilbert C. White, II
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures